Delcath Systems, Inc. financial data

Symbol
DCTH on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
566 Queensbury Avenue, Queensbury, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 265 % +70.9%
Quick Ratio 28.4 % +74.7%
Debt-to-equity 163 %
Return On Equity -380 % -169%
Return On Assets -144 % +3.55%
Operating Margin -304 % +75.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28M shares +83.3%
Common Stock, Shares, Outstanding 27.9M shares +83.2%
Entity Public Float 81.7M USD
Common Stock, Value, Issued 279K USD +82.4%
Weighted Average Number of Shares Outstanding, Basic 28.4M shares +128%
Weighted Average Number of Shares Outstanding, Diluted 28.4M shares +128%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 7.77M USD +1469%
Revenue from Contract with Customer, Excluding Assessed Tax 11.9M USD +351%
Cost of Revenue 2.73M USD +239%
Research and Development Expense 16.5M USD -0.97%
Operating Income (Loss) -36.1M USD -11.4%
Net Income (Loss) Attributable to Parent -56.3M USD -67.9%
Earnings Per Share, Basic -2.52 USD/shares +19.5%
Earnings Per Share, Diluted -2.52 USD/shares +19.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.8M USD +1.66%
Accounts Receivable, after Allowance for Credit Loss, Current 3.73M USD +2834%
Inventory, Net 6.32M USD +155%
Assets, Current 31.4M USD +61.3%
Property, Plant and Equipment, Net 1.42M USD +1.35%
Operating Lease, Right-of-Use Asset 1.09M USD +524%
Assets 33.9M USD +61.1%
Accounts Payable, Current 3.28M USD +239%
Employee-related Liabilities, Current 2.3M USD +73.3%
Accrued Liabilities, Current 4.42M USD -20.3%
Liabilities, Current 12.3M USD +10.6%
Operating Lease, Liability, Noncurrent 989K USD
Other Liabilities, Noncurrent 632K USD -44.9%
Liabilities 29.7M USD +39.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 8K USD
Retained Earnings (Accumulated Deficit) -530M USD -11.9%
Stockholders' Equity Attributable to Parent 4.19M USD
Liabilities and Equity 33.9M USD +61.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.58M USD -125%
Net Cash Provided by (Used in) Financing Activities 4.02M USD -75.9%
Net Cash Provided by (Used in) Investing Activities 4.66M USD
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 27.9M shares +83.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -886K USD -107%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.8M USD +1.37%
Interest Paid, Excluding Capitalized Interest, Operating Activities 250K USD -49.1%
Deferred Tax Assets, Valuation Allowance 39.3M USD +21.5%
Deferred Tax Assets, Gross 39.3M USD +21.4%
Operating Lease, Liability 1.09M USD +609%
Depreciation 127K USD -3.05%
Payments to Acquire Property, Plant, and Equipment 13K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -56.3M USD -68.4%
Lessee, Operating Lease, Liability, to be Paid 1.55M USD +828%
Property, Plant and Equipment, Gross 6.55M USD +2.23%
Operating Lease, Liability, Current 103K USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169K USD +369%
Lessee, Operating Lease, Liability, to be Paid, Year One 187K USD +419%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 458K USD +3423%
Lessee, Operating Lease, Liability, to be Paid, Year Three 148K USD +605%
Deferred Tax Assets, Operating Loss Carryforwards 29.9M USD +21.5%
Preferred Stock, Shares Issued 12.3K shares -41.2%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 153K USD
Operating Lease, Payments 13K USD -87.7%
Additional Paid in Capital 534M USD +12.8%
Preferred Stock, Shares Outstanding 12.3K shares -41.2%
Share-based Payment Arrangement, Expense 10.8M USD +84.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%